Login / Signup

Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30 + lymphoproliferative disorder: A case report.

Giulia CeglieRita De VitoMatilde CossuttaAlice TiberiRoberto CartaEmilia BoccieriGiuseppe Palumbo
Published in: Pediatric blood & cancer (2022)
Keyphrases
  • hodgkin lymphoma
  • epstein barr virus
  • combination therapy